Skip to main content

Table 3 NAT2 allele frequency in AD cases and controls.

From: NAT gene polymorphisms and susceptibility to Alzheimer's disease: identification of a novel NAT1 allelic variant

NAT2 ALLELE

AD CASES (N = 45)

CONTROLS (N = 63)

OR (95% CI)

2*4

20 (0.22)

26 (0.21)

1.00

2*5A

1 (0.01)

4 (0.03)

0.33 (0.03, 3.14)

2*5B

35 (0.39)

53 (0.42)

0.86 (0.42, 1.77)

2*5C

1 (0.01)

2 (0.02)

0.65 (0.06, 7.69)

2*6A

32 (0.36)

39 (0.31)

1.07 (0.51, 2.25)

2*7B

1 (0.01)

2 (0.02)

0.65 (0.06, 7.69)

TOTAL

90 (1.00)

126 (1.00)

-

  1. The number and frequency (in brackets) of NAT2 alleles in 45 AD cases and 63 controls is shown. The OR of AD to non-disease is given with 95% CI for each NAT2 allele (with NAT2*4 as the reference group).
Back to article page

BMC Medical Genetics

ISSN: 1471-2350

Contact us